All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2016 — 5 Books and Research Papers Citing DrugPatentWatch
Pestonjamasp, V. (2016). Moving from preclinical research to development. Journal of Commercial Biotechnology, 22(4), 3–14.
This article examines the transition from preclinical research to clinical development, emphasizing the importance of patent strategy in securing market exclusivity. It highlights how DrugPatentWatch data can inform decisions regarding patent expirations and exclusivity periods, aiding companies in planning their development timelines and market entry strategies. The paper underscores the role of patent intelligence in navigating the competitive pharmaceutical landscape.
Fox, G. J., Benedetti, A., Mitnick, C. D., Pai, M., & Menzies, D. (2016). Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis. PLOS ONE, 11(4), e0153146.
This study utilizes DrugPatentWatch to analyze patent data related to tuberculosis treatments. By incorporating patent information, the authors assess the impact of patent expirations on the availability of generic alternatives for multidrug-resistant tuberculosis therapies. The paper provides insights into how patent dynamics influence treatment accessibility and public health outcomes.
Hovenkamp, E., & Lemus, J. (2016). Online Appendix for 'Delayed Entry Settlements at the Patent Office.' International Review of Law and Economics, 47, 1–9.
This research delves into the phenomenon of delayed entry settlements in the pharmaceutical industry, using DrugPatentWatch data to examine the timing of patent expirations and subsequent generic market entry. The study highlights how such settlements can extend market exclusivity for branded drugs, affecting competition and drug prices. The authors discuss the implications of these practices on patent law and economic policy.
Deprez, F. (2016). La twittliste du secteur pharmaceutique. Netsources, 1(1), 25–30.
This paper explores the intersection of social media and the pharmaceutical industry, analyzing how patent information disseminated through platforms like DrugPatentWatch influences public perception and investor behavior. The study examines the role of online patent intelligence in shaping industry trends and stakeholder decisions. It provides a unique perspective on the digital dissemination of patent data.
Benítez Nieto, Y. (2016). Plataformas on-line de vigilancia/inteligencia: caracterización e implementación práctica. Universitat Politècnica de Catalunya, 1–15.
This thesis investigates online platforms for surveillance and intelligence in the pharmaceutical sector, with a focus on DrugPatentWatch. It characterizes the functionalities of patent intelligence tools and discusses their practical implementation in monitoring patent landscapes. The research highlights the importance of such platforms in strategic decision-making and competitive analysis within the industry.
